Scientists nominated CDC7 inhibition as a therapeutic strategy to constrain lineage plasticity, as well as to effectively treat neuroendocrine tumors de novo or after transformation.
[Signal Transduction and Targeted Therapy]
Home Newsletters CDC7 Inhibition Impairs Neuroendocrine Transformation in Lung and Prostate Tumors through MYC...
